简介内容:EtDO-P4 is a nanomolar inhibitor of sphingolipid (GSL) synthesis. etDO-P4 inhibits EGFR-induced activation of the ERK pathway and various receptor tyrosine kinases (RTK). etDO-P4 can be used to study a variety of tumor types, such as Burkitt´s lymphoma.